LFMD · LifeMD Inc
United States · RS rating 6 · As of 2026-10-14
| Price | 2.37 USD |
|---|---|
| 1-day change | -4.0% |
| RS rating (overall / 1M / 3M / 12M) | 6 / 6 / 6 / 11 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 22 / 5 / 29 |
| Industry group (rank) | Medical-Products (98) |
| EPS growth Q/Q | +510.0% |
| Sales growth Q/Q | -88.2% |
| Distance from 52-week high | +63.1% |
| Market cap (USD) | $214.9M |